Navigation Links
Sequenom Reports Fourth Quarter and Full Year 2010 Financial Results
Date:3/8/2011

lly raised gross proceeds of approximately $148 million in two financings to fund ongoing operations.

Genetic Analysis Segment – In April 2010 the company launched its next generation MassARRAY analyzer for the research use only community. The business segment continues to grow and realized an approximate 19% year-over-year growth. During 2010 the company shipped 51 MassARRAY analyzers.

Regulatory – In October 2010 the company submitted a pre-IDE package to the FDA for its SEQureDx™ Trisomy 21 test.

Sequenom CMM – During 2010 Sequenom CMM achieved a number of important milestones:

  • Introduced the SensiGene® Fetal RHD Genotyping LDT in February
  • Completed the T21 'locked-assay' study in September
  • Built, equipped and licensed  our CLIA laboratory, located in San Diego in October to support our planned SensiGene Trisomy 21 LDT launch
  • Initiated SensiGene T21 LDT clinical validation study in December
  • Completed the SensiGene age related macular degeneration (AMD)LDT in silico validation study in December

  • 2011 ProgramsTrisomy 21 Program Update – In December 2010 Sequenom CMM initiated its clinical validation study for the Trisomy 21 LDT. The company expects that Sequenom CMM will complete the study by the middle of 2011 and a manuscript reporting the results will be submitted shortly thereafter.  We anticipate publication of this key study by the end of 2011 or early 2012.

    The company initiated discussion with the FDA in January 2011 regarding the necessary preclinical and clinical studies required to support a premarket approval application to the FDA for an in vitro diagnostic device for trisomy 21. The company anticipates continuing a constructive dialog with the FDA over the coming months.

    In March 2011, results from the Trisomy 21 "locked-assay" study were published in the American Journal of Obste
    '/>"/>

    SOURCE Sequenom, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. University of Michigan Study Shows SEQUENOMs MassARRAY Technology Identifies HPV Infections Missed by Standard Hybridization Test
    2. Sequenom Announces Paul Maier to Become Interim Chief Financial Officer
    3. Sequenom Announces Addition to Clinical Advisory Board
    4. Sequenom Announces Settlement Agreement In Shareholder Class Action Lawsuit
    5. Sequenom Announces Launch of SensiGene Fetal(XY) (Fetal Sex Determination) Test
    6. Sequenom Reports 2009 Fourth Quarter and Full Year Financial Results
    7. Sequenom Announces Final Approval of Settlement in Class Action Securities Lawsuit
    8. Sequenom to Present at the Jefferies 2010 Global Life Sciences Conference
    9. Sequenom Announces Date of Second Quarter 2010 Financial Results and Conference Call
    10. Sequenom to Present at Two Financial Conferences in November
    11. Sequenom CMM Commences Pivotal Clinical Validation Study for Its SensiGene Trisomy 21 Laboratory Developed Test
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... , Jan. 15, 2014  Valeant Pharmaceuticals International, Inc. ... that the applicable waiting period under the Hart-Scott-Rodino Antitrust ... previously announced tender offer by its indirect wholly-owned subsidiary, ... shares of common stock of Solta Medical, Inc. (NASDAQ: ...
    (Date:1/15/2014)... Ohio , Jan. 15, 2014  A novel wearable injector ... easy and painless for patients to self-inject prescription drugs in ... disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic disorders.  ... to grow to $220B by 2018, according to analysts.   Many ...
    (Date:1/14/2014)... , Jan. 14, 2014 The Brandeis Medical Center, led ... a premier and affordable laser tattoo removal experience with ... Brandeis, focus is in providing high quality cosmetic services with cutting ... " Southern California has seen a ...
    Breaking Medicine Technology:Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Beverly Hills Physician Features Tattoo Removal with the Astanza Duality Laser, Offers $99 Special 2
    ... 11 Nutri-Force Nutrition is proud to announce ... in Miami Lakes, Florida. This new facility was ... highly-valued customers with industry-leading quality and exceptionally efficient ... and innovative production control processes, the new facility ...
    ... and NEW YORK, Nov. 10 Inc. magazine has ... Inc. 5000 list of the fastest-growing private companies in the U.S. ... of the Top 100 Health Companies and No. 32 on the ... West Physics Consulting posted three-year revenue growth of 327.8% to ...
    Cached Medicine Technology:West Physics Consulting Makes the 2009 Inc. 5000 List 2
    (Date:4/17/2014)... San Diego School of Medicine report that older women, ... major loss are more likely to be compassionate toward ... published in this month,s issue of the International ... are associated with better health and well-being as we ... improve the outcomes of individuals whose deficits in compassion ...
    (Date:4/17/2014)... the April issue of Immunity , Kevin J. ... Research, says it,s time to take a fresh look ... sepsis, which kills millions worldwide every year, including more ... into the bloodstream to fight an injury or infection ... maintaining good health without inflammation, wounds and infections ...
    (Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
    (Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
    (Date:4/17/2014)... NY (April 16, 2014) The cause of neuronal ... new study proposes that neurons may be mistaken for ... system, similar to the way autoimmune diseases like type ... body,s cells. The study was published April 16, 2014, ... new, and likely controversial, idea in Parkinson,s disease; but ...
    Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2
    ... international study involving researchers from the Sahlgrenska Academy at ... revealed that aspirin, statins, beta blockers and ACE inhibitors ... medicines that could prevent a huge number of deaths ... of a research collaboration between 17 countries, the study ...
    ... over the past three decades should inspire a new worldwide ... public health leaders. A UN summit will offer a rare ... these diseases. In a perspective article in this week,s ... cite the need for a collective global effort to stem ...
    ... Gordon HealthDay Reporter , WEDNESDAY, Sept. 7 (HealthDay ... a risk factor for death among black women, according to ... is, the greater her risk of dying sooner than her ... with rising body mass index (BMI). Once women were above ...
    ... Gonzalez-Guarda, Ph.D., R.N., an assistant professor at the University ... won a competitive grant from the Robert Wood Johnson ... for preventing teen dating violence among Hispanics. Gonzalez-Guarda is ... country to receive the three-year $350,000 Nurse Faculty Scholar ...
    ... News) -- Introducing powder-free latex gloves into health care facilities ... study shows. Researchers followed more than 800 health care ... tested the amount of latex allergen in the air ducts ... hospitals switched to powder-free latex gloves. There was a ...
    ... [Brown University] -- Thousands of college football players began competing ... of the new season comes new data on the risks ... backs and quarterbacks suffer the hardest hits to the head, ... often. The researchers measured head blows during games and practices ...
    Cached Medicine News:Health News:Cheap drugs could save thousands of lives - in Sweden alone 2Health News:Global fight against non-communicable diseases should take lessons from HIV-AIDS 2Health News:Global fight against non-communicable diseases should take lessons from HIV-AIDS 3Health News:Extra Pounds a Deadly Risk Factor for Black Women: Study 2Health News:Extra Pounds a Deadly Risk Factor for Black Women: Study 3Health News:UM Gonzalez-Guarda wins grant from Robert Wood Johnson Foundation 2Health News:UM Gonzalez-Guarda wins grant from Robert Wood Johnson Foundation 3Health News:Switch to Powder-Free Latex Gloves Cuts Health Workers' Allergy Risk 2Health News:Running backs take hardest hits to the head, linemen take the most 2Health News:Running backs take hardest hits to the head, linemen take the most 3
    Large, bright images from a bronchoscope designed for routine examination and treatment....
    ... the first in a series of bronchofiberscopes ... features necessary to meet the demand for ... scope includes a new control section and ... It also provides a wider field of ...
    ... Double lumen ... one-lung ventilation., ... Tube is packaged ... tube-to-circuit adaptors, suction ...
    ... Used for endobronchial blockade ... right lung for procedures ... The set consists of ... and an Arndt Multiport ...
    Medicine Products: